Clinical Trials Insight: 700047464
Latest Information Update: 03 Aug 2009
At a glance
- Drugs Telatinib (Primary) ; Capecitabine; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bayer
- 03 Aug 2009 New trial record.
Latest Information Update: 03 Aug 2009